Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20190328002
TCTR20190328002
Completed
未知

THE EVALUATION OF THE EFFECTS OF THREE DIFFERENT POSTOPERATIVE ANALGESIC METHODS ON THIOL/DISULPHIDE HOMEOSTASIS

none0 sites60 target enrollmentMarch 28, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsoxitadive stres&#44pain&#44femur fracturedisulphide&#44oxidative stres&#44thiol

Overview

Phase
未知
Intervention
Not specified
Conditions
oxitadive stres&#44
Sponsor
none
Enrollment
60
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 28, 2019
End Date
March 20, 2018
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
none

Eligibility Criteria

Inclusion Criteria

  • •proximal femur fracture, femoral nail operation, ASA I\-III

Exclusion Criteria

  • •need of postoperative intensive care admission, chronical analgesic use, norological imparement at lower extremities, coagulopathy

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
The effects of oral care program on oropharyngeal complications and the Occurrence of ventilator associated pneumoniaCondition 1: ventilator associated pneumonia. Condition 2: oropharyngeal complications.Ventilator associated pneumoniaJ95.851
IRCT20191012045066N1Esfahan University of Medical Sciences66
Active, not recruiting
Not Applicable
EXPLORATORY STUDY OF THE EFFECT OF THREE DIFFERENT LEVELS OF DOSES OF TAMOXIFEN (20, 40 Y 60 MG/DAY) OVER THE PLASMATIC CONCENTRATION OF THE MAIN ACTIVE TAMOXIFEN METABOLITE (ENDOXIFEN) IN PATIENTS WITH HORMONO-SENSITIVE BREAST CANCER, CARRIERS OF A CYP2D6 GENOTYPE POOR METABOLIZER”.Estudio exploratorio del efecto de tres diferentes niveles de dosis de tamoxifeno (20, 40 y 60 mg/día) sobre la concentración plasmática de su principal metabolito activo (endoxifeno) en pacientes con cáncer de mama hormonodependiente portadoras de un genotipo de CYP2D6 metabolizador lento”WOMEN WITH HORMONE-DEPENDENT RESECTED PRIMARY BREAST CANCER, WITHOUT EVIDENCE OF METASTATIC DISEASE AND CARRIERS OF A CYP2D6 GENOTYPE POOR METABOLIZER”.Cáncer de mama operado y sin diseminación metastásica (AJCC, 2002), con receptores hormonales positivos (receptor estrogénico RE y/o receptor de progesterona RP).Las pacientes deberán ser lentas metabolizadoras” de CYP2D6
EUCTR2007-002942-40-ESFundación de la Comunidad Valenciana Hospital Provincial de Castellón
Not yet recruiting
Phase 3
Investigating and comparing the effect of three therapeutic methods of Naproxen, hydroxyzine and Syrup Noscough as therapeutic methods for preventing bone pain caused by granulocyte-colony stimulating factor(GCSF )in cancer patients
IRCT20231227060538N1Shahid Beheshti University of Medical Sciences123
Completed
Not Applicable
Examination of the effectiveness of three different toothpastes in reduction of dental hypersensitivityHypersensitivity
DRKS00014839Förderverein Universität Witten/ Herdecke95
Not yet recruiting
Not Applicable
Comparison of the effects of three different volumes and concentration a Local Anaesthesia in Ultrasound Guided Supraclavicular block
CTRI/2021/07/035024M Aruna Manaswini